| Jacob Dufour, OD | |
|
101 Dawn Dr, Centerton, AR 72719-9314 | |
| (479) 795-1411 | |
| (479) 795-1412 |
| Full Name | Jacob Dufour |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 9 Years |
| Location | 101 Dawn Dr, Centerton, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730556580 | NPI | - | NPPES |
| Provider Name | Petty And Petty P A |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457412991 PECOS PAC ID: 7517063159 Enrollment ID: O20070427000587 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that it has completed the acquisition of effectively 100% of the outstanding shares of Taiyo Pharmaceutical Industry Co. Ltd. for $934 million in cash.
A breakthrough by scientists at the University of Leicester in understanding mechanisms within the brain which cause injury could lead to better treatments in the future for conditions such as as cerebral palsy and multiple sclerosis.
ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its new Octet QK(e) instrumentation system. The new system, the next generation of the company's initial eight-channel Octet QK instrument, provides significantly increased sensitivity, enabling analysis of small proteins and peptides. Additionally, the Octet QK(e) system enables biosensors to be re-racked, for increased workflow flexibility and cost savings.
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes.
› Verified 9 days ago
| Provider Name | Bright Eyes Vision Care Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275116832 PECOS PAC ID: 9537569850 Enrollment ID: O20210608002467 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that it has completed the acquisition of effectively 100% of the outstanding shares of Taiyo Pharmaceutical Industry Co. Ltd. for $934 million in cash.
A breakthrough by scientists at the University of Leicester in understanding mechanisms within the brain which cause injury could lead to better treatments in the future for conditions such as as cerebral palsy and multiple sclerosis.
ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its new Octet QK(e) instrumentation system. The new system, the next generation of the company's initial eight-channel Octet QK instrument, provides significantly increased sensitivity, enabling analysis of small proteins and peptides. Additionally, the Octet QK(e) system enables biosensors to be re-racked, for increased workflow flexibility and cost savings.
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Dufour, OD 900 S 52nd St Ste 102, Rogers, AR 72758-8640 Ph: (479) 657-6006 | Jacob Dufour, OD 101 Dawn Dr, Centerton, AR 72719-9314 Ph: (479) 795-1411 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that it has completed the acquisition of effectively 100% of the outstanding shares of Taiyo Pharmaceutical Industry Co. Ltd. for $934 million in cash.
A breakthrough by scientists at the University of Leicester in understanding mechanisms within the brain which cause injury could lead to better treatments in the future for conditions such as as cerebral palsy and multiple sclerosis.
ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its new Octet QK(e) instrumentation system. The new system, the next generation of the company's initial eight-channel Octet QK instrument, provides significantly increased sensitivity, enabling analysis of small proteins and peptides. Additionally, the Octet QK(e) system enables biosensors to be re-racked, for increased workflow flexibility and cost savings.
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to speed the development of drug targets and pathways to promote the survival and function of insulin-producing cells in people who have diabetes.
› Verified 9 days ago
Dr. Megan Jo Petty, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 101 Dawn Dr, Centerton, AR 72719 Phone: 479-426-1660 | |
Centerton Family Eyecare, P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 101 Dawn Dr, Centerton, AR 72719 Phone: 479-795-1411 Fax: 479-795-1412 | |
Pediatric Vision Development Center Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 101 Dawn Dr, Centerton, AR 72719 Phone: 479-795-1411 Fax: 479-795-1412 | |
Dr. Regan Skye Petty, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 101 Dawn Dr, Centerton, AR 72719 Phone: 479-426-1660 |